Cargando…
Screening for comorbidities in COPD
Due to growing recognition of comorbidities, COPD is no longer considered a disease affecting only the respiratory system. Its management now entails the early diagnosis and treatment of comorbidities. However, although many studies have examined the impact of comorbidities on the evolution of COPD...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249790/ https://www.ncbi.nlm.nih.gov/pubmed/32494303 http://dx.doi.org/10.1183/20734735.0315-2019 |
_version_ | 1783538657069629440 |
---|---|
author | Natali, Delphine Cloatre, Georges Hovette, Philippe Cochrane, Belinda |
author_facet | Natali, Delphine Cloatre, Georges Hovette, Philippe Cochrane, Belinda |
author_sort | Natali, Delphine |
collection | PubMed |
description | Due to growing recognition of comorbidities, COPD is no longer considered a disease affecting only the respiratory system. Its management now entails the early diagnosis and treatment of comorbidities. However, although many studies have examined the impact of comorbidities on the evolution of COPD and patients’ quality of life, very few have explored the means to systematically identify and manage them. The aims of this article are to summarise the state of current knowledge about comorbidities associated with COPD and to propose a possible screening protocol in the outpatient setting, emphasising the areas needing further research. |
format | Online Article Text |
id | pubmed-7249790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-72497902020-06-02 Screening for comorbidities in COPD Natali, Delphine Cloatre, Georges Hovette, Philippe Cochrane, Belinda Breathe (Sheff) Reviews Due to growing recognition of comorbidities, COPD is no longer considered a disease affecting only the respiratory system. Its management now entails the early diagnosis and treatment of comorbidities. However, although many studies have examined the impact of comorbidities on the evolution of COPD and patients’ quality of life, very few have explored the means to systematically identify and manage them. The aims of this article are to summarise the state of current knowledge about comorbidities associated with COPD and to propose a possible screening protocol in the outpatient setting, emphasising the areas needing further research. European Respiratory Society 2020-03 /pmc/articles/PMC7249790/ /pubmed/32494303 http://dx.doi.org/10.1183/20734735.0315-2019 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Reviews Natali, Delphine Cloatre, Georges Hovette, Philippe Cochrane, Belinda Screening for comorbidities in COPD |
title | Screening for comorbidities in COPD |
title_full | Screening for comorbidities in COPD |
title_fullStr | Screening for comorbidities in COPD |
title_full_unstemmed | Screening for comorbidities in COPD |
title_short | Screening for comorbidities in COPD |
title_sort | screening for comorbidities in copd |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249790/ https://www.ncbi.nlm.nih.gov/pubmed/32494303 http://dx.doi.org/10.1183/20734735.0315-2019 |
work_keys_str_mv | AT natalidelphine screeningforcomorbiditiesincopd AT cloatregeorges screeningforcomorbiditiesincopd AT hovettephilippe screeningforcomorbiditiesincopd AT cochranebelinda screeningforcomorbiditiesincopd |